Hepatitis B is one of the world’s most common infectious diseases. About 350 million people have the virus. Every year between 500,000 to one million people die of HBV-related chronic hepatitis, cirrhosis or liver cancer. Almost 94,000 people have hepatitis B in New Zealand.
Screening for Hepatitis B virus is routinely performed by testing for serologic markers (hepatitis B surface antigen, hepatitis core antigen, hepatitis B surface antibody). Nucleic acid tests for HBV DNA are used as an aid in the management of patients with chronic HBV infection undergoing anti-viral therapy and to measure HBV DNA levels at baseline and during treatment to aid in
assessing response to treatment.
Microbiology - Virology
DHBV
Dedicated EDTA tubes required, minimum 4mL whole blood
Please refer to separating guide in Additional Information section below
If sample arrives frozen, please ensure it does not thaw.
Add-on requests for Viral load testing are only able to be performed if other plasma viral loads have been requested as dedicated sterile samples are required. Viral loads cannot be added to samples previously processed for CBC testing. Please call virology on ext 80356 to discuss.
HBV DNA
HBV viral load
5 days
2740